A total of 10 individuals with HIV have been cured to date. Most of these patients have remained anonymous, but three have ...
A groundbreaking deal will make a new HIV prevention drug affordable in over 100 low-income countries, potentially advancing ...
A man living with advanced HIV carried COVID-19 for more than 750 days. During the chronic infection, the virus mutated ...
DelveInsight's DNA Synthesis Inhibitors Market Size, Target Population, Competitive Landscape & Market Forecast report includes a ...
Durban developer Leon Chetty uses human-AI symbiosis to design HIV nanocarriers, claiming that collaboration could accelerate ...
The DNA synthesis inhibitors market is projected to witness substantial growth in the coming years, driven by the rising incidence of cancer diagnoses, growing awareness, the expanding pipeline ...
Tick-borne encephalitis virus can infect the nervous system and cause life-threatening illness. Finding the cellular gateway ...
HIV globally, and that number continues to rise. While therapies exist to reduce the amount of HIV in a patient's body and, in turn, reduce HIV symptoms, there remains no cure. Engineering better ...
Oral presentation highlights significant reduction in HBV DNA integration and other clinically-relevant biomarkers from the EBT-107 therapeutic ...
Learn more about the longest documented case of COVID-19 found in an American man living with HIV.
The stock-trading website Raging Bull just gave Cocrystal Pharma, a clinical-stage biotech, a big thumbs up for its ...